Press release
Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Will Generate Record Revenue by 2029
MRSA is spread in two out of every 100 people, according to the Centers for Disease Control and Prevention (CDC). In 2020, the number of people who were diagnosed with methicillin-resistant Staphylococcus aureus (MRSA) for the first time was significantly lower than in prior years. 2,883 cases were reported in 2020, compared to 3,657 cases in 2019, 3,669 cases in 2018, 3,579 cases in 2017, and 3,550 cases in 2016. Patients staying in long-term health care institutions for an extended period of time are a crucial component in the outbreak of MRSA infections. According to the Healthcare Cost & Utilization Project (HCUP), a collection of healthcare databases in the US, hospitalized patients are more likely than non-hospitalized patients who died from MRSA infections (4.7% vs. 2.1% respectively).
Improved detection of antibiotic-resistant bacterium strains utilizing technologically sophisticated diagnostic methods, as well as an increase in antibiotic use across the globe, are likely to propel the growth of the global MRSA antibiotic preparations market. Teixobactin, according to University of Melbourne experts, is effective against MRSA. These findings are anticipated to pave the way for the development of antibacterial medications to treat Gram-positive infections with thick cell walls that are multidrug-resistant. This will support accelerating the market growth.
To Request a Sample of our Report on Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market: https://www.omrglobal.com/request-sample/methicillin-resistant-staphylococcus-aureus-mrsa-drugs-market
Market Coverage
• The market number available for - 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
Segment Covered-
· By Drug Class
· By Route of Administration
· By Distribution Channel
Regions covered-
· North America
· Europe
· Asia-Pacific
· Rest of the World
Competitive Landscape: Pfizer Inc., Merck & Co. Inc, and AbbVie Inc. among others.
MRSA Drugs Market Report by Segment
By Drug Class
• Lipopeptide
• Oxazolidinone
• Tetracycline
• Cephalosporin
• Lipoglycopeptide
• Others
By Route of Administration
• Oral
• Parenteral
By Distribution Channel
• Online Pharmacy
• Hospital Pharmacy
• Retail Pharmacy
A full Report of Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market is Available @ https://www.omrglobal.com/industry-reports/methicillin-resistant-staphylococcus-aureus-mrsa-drugs-market
MRSA Drugs Market by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
· Latin America
· Middle East and Africa
Reasons to buy from us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/methicillin-resistant-staphylococcus-aureus-mrsa-drugs-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Will Generate Record Revenue by 2029 here
News-ID: 3229366 • Views: 295
More Releases from Orion Market Research
User Provisioning Market Analysis, Size, Current Scenario and Future Prospects
User Provisioning Market is expected to grow at a significant CAGR during the forecast period. User provisioning is also known as account provisioning. It comprises a software system that provides the organization and businesses to manage data mainly user's information available on various systems and applications with optimum security. The user provisioning system in terms of its action was quick, efficient, and secure.
The global user provisioning market is expected to…
User Activity Monitoring UAM Market is Anticipated to Increase at a Stable CAGR …
User activity monitoring (UAM) market is expected to grow at a significant CAGR during the forecast period. User Activity Monitoring (UAM) is an advanced solution that record and monitors the actions of a user. This UAM solution allows enterprises to track the complete activities performed by the employees. The UAM features are induced in various organizations to track security and inhibit the security issue that leads to the hijacking of…
Underwater Wireless Communication Market Booming Worldwide with Latest Trend and …
The global underwater wireless communication market is expected to grow at a significant CAGR during the forecast period. Several industries near the coast have deployed an underwater wireless communication network to provide support services for maritime applications. The demand for monitoring pollutants in the aquatic environment and identification of things under the sea has raised the scope of the underwater wireless communication market, owing to an increase in offshore oil…
T Cell Surface Glycoprotein CD Market is Anticipated to Increase at a Stable CAG …
T cell surface glycoprotein CD market is anticipated to grow at a significant CAGR during the forecast period. CD is a glycoprotein that serves as a co-receptor for the T-cell receptor (TCR). CD4 is found on the surface of immune cells such as T helper cells, monocytes, macrophages, and dendritic cells. The major factor driving the demand for the global t cell surface glycoprotein CD4 market during the forecast period…
More Releases for MRSA
VRE and MRSA Antibiotic Market 2021 | Detailed Report
According to Market Study Report, VRE and MRSA Antibiotic Market provides a comprehensive analysis of the VRE and MRSA Antibiotic Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample PDF (including full TOC, Tables and Figures) of VRE and MRSA Antibiotic Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4645656
The…
MRSA Testing Market Analysis of Top industry Scenario
Global MRSA Testing Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables).
According to a new report published by Allied Market Research, titled, "Global MRSA Testing Market by Type (Immunodiagnostics and Molecular Diagnostics) By…
Find out Why MRSA Antibiotics Market Is Thriving Worldwide
A new market study on Global (United States, European Union and China) MRSA Antibiotics Market with 100+ market data Tables, Pie Chart & Graphs is released that will provide complete assessment of the Market and covers evolving trends, current scenario analysis and growth factors, and industry validated market data. The research study provides market breakdown by revenue and volume (if applicable) and price history estimates for Global (United States, European…
Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market – Driver
Methicillin-Resistant Staphylococcus Aureus (MRSA) is a type of staphylococcus aureus, which became resistant to methicillin, amoxicillin, penicillin, oxacillin, and other such commonly used antibiotics. Staphylococcus aureus harbors on the skin and nasal passage of about one third of the world population, which comprises around 33%, as per Centers for Disease Control and Prevention (CDC) review 2015. MRSA can be classified into two types, based on mode of infection – Hospital…
Global MRSA Testing Devices Market Highlights and Challenges 2017
Qyresearchreports include new market research report "Global MRSA Testing Devices Market Professional Survey Report 2017" to its huge collection of research reports.
The global MRSA Testing Devices market has been elaborately studied, researched and detailed on in this publication by taking the assistance of advanced secondary and primary research that has been performed by the best of analysts and by making use of the best of the available techniques. The said…
Global MRSA Antibiotics Market: Scenario 2025
“Global MRSA Antibiotics Industry Report" is an expert and in-depth analysis of key business and future development prospects, key determinants and restrictions, profiles of major market players, segmentation and forecasting. The study offers a comprehensive qualitative analysis of the industry's growth parameters, the current state of the market in terms of analysis of key economic situations and macroeconomic analysis. The analysis highlights the growth opportunities of key market segments along…
